RxCONNECT

Nov 7, 2022

Committed to pediatric health. Learn more Innovative therapies for complex conditions. Learn more A family of innovative products that’s perfect for yours. Learn more Advancing innovations in ADHD. Learn more RxConnect. Putting patients first. Aytu RxConnect is a...

Unsubscribed

Sep 9, 2022

Unsubscribed You have been successfully unsubscribed from our email list. Email communications from @mg.aytubio.com will cease within two business days. In the meantime, feel free to browse our product websites. If you accidentally unsubscribed, just reach out to...

Protected: About

Jun 29, 2022

Password Protected

To view this protected post, enter the password below:

Insider Trading Policy

Oct 27, 2021

Policy Name:Insider Trading Policy SOP Owner:Human Resources Policy Number:HR101-07012021 Effective Date:7/1/2021 Applicable to:All Aytu BioPharma Employees Last Revision Date: Scope and Purpose This Policy Statement summarizes the policies of Aytu BioPharma,...

PREVEnt Clinical Trial

Oct 10, 2021

Join the PREVEnt Trial for Vascular Ehlers-Danlos Syndrome AR101 (enzastaurin) Clinical Development PREVEnt Trial Prevention of Rupture with Enzastaurin in Vascular Ehlers-Danlos Syndrome The PREVEnt Trial is evaluating the effectiveness of AR101 (enzastaurin) in...